Answers are grounded in this paper and cite their sources.
More evidence supports the benefits of batroxobin combined with anticoagulation in correcting acute cerebral venous thrombosis (CVT). The dynamic fluctuations of peripheral blood platelets, fibrinolysis, and coagulation biomarkers during this therapy were analyzed.
No takes yet. Share an insight, caveat, or question.
Lan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: